Tellimer logo
Search icon
Equity Analysis /
United States of America

US : Flexion Therapeutics, Inc. - FLXN | 1Q21 Financial Result; Zilretta Recovery Thesis Remains Intact With Key Data Readouts in 2021

    Contributors
    Lucas Lee
    Michael Parolari
    CGS-CIMB
    13 May 2021
    Published by

    Watchlist

    Tellimer | Start Following

    Start following your markets today

    Follow your key analysts, markets and more so they appear here in your Watchlist - allowing you to keep an eye on the latest updates.